Stifel Financial Corp View Ray, Inc. Transaction History

Stifel Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.28 - $4.81 $662 - $971	-202 Reduced 0.35%	57,948 $200,000
Q4 2022 Feb 13, 2023	SELL	$3.65 - $4.82 $45,300 - $59,821	-12,411 Reduced 17.59%	58,150 $260,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $3.97 $7,980 - $11,910	3,000 Added 4.44%	70,561 $257,000
Q2 2022 Aug 15, 2022	BUY	$2.42 - $4.05 $32,052 - $53,642	13,245 Added 24.39%	67,561 $179,000
Q1 2022 May 13, 2022	BUY	$3.45 - $5.83 $187,390 - $316,662	54,316 New	54,316 $213,000
Q4 2019 Feb 13, 2020	SELL	$2.3 - $4.6 $29,313 - $58,626	-12,745 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$2.9 - $9.56 $36,960 - $121,842	12,745 New	12,745 $39,000
Q4 2018 Feb 13, 2019	SELL	$5.04 - $10.28 $175,432 - $357,826	-34,808 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$7.12 - $12.44 $247,832 - $433,011	34,808 New	34,808 $328,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.